Is insight in schizophrenia multidimensional? Internal structure and associations of the Greek version of the Schedule for the Assessment of Insight-Expanded

Psychiatry Research

Volumn 209, Issue 3, 2013, Pages 346-352

  Konstantakopoulos, George ^a,b   Ploumpidis, Dimitris ^a   Oulis, Panagiotis ^a   Soumani, Aggeliki ^a   Nikitopoulou, Stavrina ^a   Pappa, Konstantina ^a   Papadimitriou, George N ^a   David, Anthony S ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cognition; Psychopathology; Psychosis; Treatment compliance; Unawareness of illness

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; COGNITIVE DEFECT; CORRELATIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; EXCITEMENT; FEMALE; GREECE; HUMAN; INTELLIGENCE; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; PATIENT ASSESSMENT; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY; SCHEDULE FOR THE ASSESSMENT OF INSIGHT EXPANDED; SCHIZOPHRENIA; VALIDITY;

COGNITION; PSYCHOPATHOLOGY; PSYCHOSIS; TREATMENT COMPLIANCE; UNAWARENESS OF ILLNESS;

ADULT; AWARENESS; COGNITION DISORDERS; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84885472438     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.02.016     Document Type: Article

References (59)

1. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 1992, 6:201-208.
2. Aleman A., Agrawal N., Morgan K.D., David A.S. Insight in psychosis and neuropsychological function: meta-analysis. British Journal of Psychiatry 2006, 189:204-212.
3. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. American Journal of Psychiatry 1993, 150:873-879.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Publishing, Inc., Washington, DC, Text revision. 4th ed.
5. Ayesa-Arriola R., Rodriguez-Sanchez J.M., Morelli C., Pelayo-Teran J.M., Perez-Iglesias R., Mata I., Martinez-Garcia O., Pardo-Garcia G., Vazquez-Barquero J.L., Crespo-Facorro B. Insight dimensions in first-episode psychosis patients: clinical, cognitive, pre-morbid and socio-demographic correlates. Early Intervention in Psychiatry 2011, 5:140-149.
6. Bazire S. Psychotropic Drug Directory 2005, Fivepin Limited, Wiltshire.
7. Beck E.M., Cavelti M., Wirtz M., Kossowsky J., Vauth R. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Psychiatry Research 2011, 187:55-61.
8. Birchwood M., Smith J., Drury V., Healy J., Macmillan F., Slade M. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica 1994, 89:62-67.
9. Borg I., Groenen P.J.F. Modern Multidimensional Scaling: Theory and Applications 1997, Springer Verlag, New York.
10. Brett-Jones J., Garety P., Hemsley D. Measuring delusional experiences: a method and its application. British Journal of Clinical Psychology 1987, 26(Pt 4):257-265.
11. Buchy L., Torres I.J., Liddle P.F., Woodward T.S. Symptomatic determinants of insight in schizophrenia spectrum disorders. Comprehensive Psychiatry 2009, 50:578-583.
12. Chang J.S., Ahn Y.M., Yu H.Y., Park H.J., Lee K.Y., Kim S.H., Kim Y.S. Exploring clinical characteristics of bipolar depression: internal structure of the bipolar depression rating scale. Australian and New Zealand Journal of Psychiatry 2009, 43:830-837.
13. Cooke M., Peters E., Fannon D., Anilkumar A.P., Aasen I., Kuipers E., Kumari V. Insight, distress and coping styles in schizophrenia. Schizophrenia Research 2007, 94:12-22.
14. Cooke M.A., Peters E.R., Kuipers E., Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatrica Scandinavica 2005, 112:4-17.
15. Crumlish N., Whitty P., Kamali M., Clarke M., Browne S., McTigue O., Lane A., Kinsella A., Larkin C., O'Callaghan E. Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder. Acta Psychiatrica Scandinavica 2005, 112:449-455.
16. Dantas C.R., Banzato C.E. Inter-rater reliability and factor analysis of the Brazilian version of the Schedule for the Assessment of Insight-Expanded Version (SAI-E). Revista Brasileira de Psiquiatria 2007, 29:359-362.
17. Dantas C.R., Banzato C.E. Predictors of insight in psychotic inpatients. Schizophrenia Research 2007, 91:263-265.
18. Dassa D., Boyer L., Benoit M., Bourcet S., Raymondet P., Bottai T. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Australian and New Zealand Journal of Psychiatry 2010, 44:921-928.
19. David A., Buchanan A., Reed A., Almeida O. The assessment of insight in psychosis. British Journal of Psychiatry 1992, 161:599-602.
20. David A., van Os J., Jones P., Harvey I., Foerster A., Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. British Journal of Psychiatry 1995, 167:621-628.
21. David A.S. Insight and psychosis. British Journal of Psychiatry 1990, 156:798-808.
22. David A.S. The clinical importance of insight: an overview. Insight and Psychosis 2004, 359-392. Oxford University Press, Oxford. X.F. Amador, A.S. David (Eds.).
23. David A.S., Morgan K.D., Maller R., Leff J., Murray R.M. Insight: unitary or multi-dimensional phenomenon?. Schizophrenia Research 2003, 60:14.
24. Donohoe G., Donnell C.O., Owens N., O'Callaghan E. Evidence that health attributions and symptom severity predict insight in schizophrenia. Journal of Nervous and Mental Disease 2004, 192:635-637.
25. Drake R.J., Lewis S.W. Insight and neurocognition in schizophrenia. Schizophrenia Research 2003, 62:165-173.
26. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 1976, 33:766-771.
27. Erickson M., Jaafari N., Lysaker P. Insight and negative symptoms as predictors of functioning in a work setting in patients with schizophrenia. Psychiatry Research 2011, 189:161-165.
28. Everitt B.S. Cluster Analysis 1993, Edward Arnold, London.
29. First, M., Spitzer, R., Gibbon, M., Williams, J., 1997. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. New York State Psychiatric Institute, Biometrics Research, New York.
30. Groth-Marant G. Handbook of Psychological Assessment 1999, J. Wiley, New York. 3rd ed.
31. Hasson-Ohayon I., Kravetz S., Roe D., David A.S., Weiser M. Insight into psychosis and quality of life. Comprehensive Psychiatry 2006, 47:265-269.
32. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
33. Kemmler G., Holzner B., Kopp M., Dunser M., Greil R., Hahn E., Sperner-Unterweger B. Multidimensional scaling as a tool for analysing quality of life data. Quality of Life Research 2002, 11:223-233.
34. Kemp R., David A. Insight and compliance. Treatment Compliance and the Therapeutic Alliance 1997, 61-84. B. Blackwell (Ed.).
35. Kongs, S.K., Thompson, L.L., Iverson, G.L., Heaton, R.K., 2000. Wisconsin Card Sorting Test-64 card version: Professional Manual. Psychological Assessment Resources, Odessa, FL.
36. Kruskal J.P., Wish M. Multidimensional Scaling 1978, Sage, Newbury Park, CA.
37. Laroi F., Fannemel M., Ronneberg U., Flekkoy K., Opjordsmoen S., Dullerud R., Haakonsen M. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Research 2000, 100:49-58.
38. Lincoln T.M., Lullmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophrenia Bulletin 2007, 33:1324-1342.
39. Lysaker P.H., Roe D., Yanos P.T. Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophrenia Bulletin 2007, 33:192-199.
40. McEvoy J.P., Apperson L.J., Appelbaum P.S., Ortlip P., Brecosky J., Hammill K., Geller J.L., Roth L. Insight in schizophrenia. Its relationship to acute psychopathology. Journal of Nervous and Mental Disease 1989, 177:43-47.
41. Mintz A.R., Dobson K.S., Romney D.M. Insight in schizophrenia: a meta-analysis. Schizophrenia Research 2003, 61:75-88.
42. Moore O., Cassidy E., Carr A., O'Callaghan E. Unawareness of illness and its relationship with depression and self-deception in schizophrenia. European Psychiatry 1999, 14:264-269.
43. Morgan K.D., David A.S. Neuropsychological studies of insight in patients with psychotic disorders. Insight and Psychosis 2004, 177-193. Oxford University Press, Oxford. X.F. Amador, A.S. David (Eds.).
44. Morgan K.D., Dazzan P., Morgan C., Lappin J., Hutchinson G., Suckling J., Fearon P., Jones P.B., Leff J., Murray R.M., David A.S. Insight, grey matter and cognitive function in first-onset psychosis. British of Journal of Psychiatry 2010, 197:141-148.
45. Quee P.J., van der Meer L., Bruggeman R., de Haan L., Krabbendam L., Cahn W., Mulder N.C., Wiersma D., Aleman A. Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. Schizophrenia Bulletin 2011, 37:29-37.
46. Roe D., Hasson-Ohayon I., Kravetz S., Yanos P.T., Lysaker P.H. Call it a monster for lack of anything else: narrative insight in psychosis. Journal of Nervous and Mental Disease 2008, 196:859-865.
47. Santone G., Rucci P., Muratori M.L., Monaci A., Ciarafoni C., Borsetti G. Attitudes toward medication in inpatients with schizophrenia: a cluster analytic approach. Psychiatry Research 2008, 158:324-334.
48. Sanz M., Constable G., Lopez-Ibor I., Kemp R., David A.S. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychological Medicine 1998, 28:437-446.
49. Segarra R., Ojeda N., Pena J., Garcia J., Rodriguez-Morales A., Ruiz I., Hidalgo R., Buron J.A., Eguiluz J.I., Gutierrez M. Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: one-year follow-up from the Eiffel study. European Psychiatry 2012, 27:43-49.
50. Sevy S., Nathanson K., Visweswaraiah H., Amador X. The relationship between insight and symptoms in schizophrenia. Comprehensive Psychiatry 2004, 45:16-19.
51. Simon A.E., Berger G.E., Giacomini V., Ferrero F., Mohr S. Insight, symptoms and executive functions in schizophrenia. Cognitive Neuropsychiatry 2006, 11:437-451.
52. Tranulis C., Lepage M., Malla A. Insight in first episode psychosis: who is measuring what?. Early Intervention in Psychiatry 2008, 2:34-41.
53. Trauer T., Sacks T. The relationship between insight and medication adherence in severely mentally ill clients treated in the community. Acta Psychiatrica Scandinavica 2000, 102:211-216.
54. van der Gaag M., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 2006, 85:280-287.
55. Vaz F.J., Bejar A., Casado M. Insight, psychopathology, and interpersonal relationships in schizophrenia. Schizophrenia Bulletin 2002, 28:311-317.
56. Wechsler D. Wechsler Adult Intelligence Scale-Revised 1981, Psychological Corporation, New York.
57. Weiler M.A., Fleisher M.H., McArthur-Campbell D. Insight and symptom change in schizophrenia and other disorders. Schizophrenia Research 2000, 45:29-36.
58. Wong S.S., Lee S., Wat K.H. A preliminary communication of an insight scale in the assessment of lithium non-adherence among Chinese patients in Hong Kong. Journal of Affective Disorders 1999, 55:241-244.
59. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64:663-667.